Orca1

FDA inspection

Cima Labs, Inc.: FDA inspection ending Sep 7, 2000

FDA inspection 36519 · Voluntary Action Indicated (VAI) · Eden Prairie, MN

Key facts

Inspection ID 36519
Firm Cima Labs, Inc.
FEI number 1000520140
Address 10000 Valley View Rd
City Eden Prairie
State MN
ZIP 55344-3510
Fiscal year 2000
Inspection end date Sep 7, 2000
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation|Generic Drug Evaluation|New Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

Other inspections at this establishment

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections